Dextromethorphan, often taken as a cough suppressant, is now approved to treat major depressive disorder (MDD) in combination with bupropion. A clinical trial found that dextromethorphan/bupropion ...

Antidepressants must be prescribed by a licensed healthcare provider — a primary care physician (PCP), psychiatrist, or nurse ...

Our providers at Huntsman Mental Health Institute (HMHI) evaluate your symptoms to make a diagnosis. Screening tools such as written questionnaires about your recent emotions, feelings, and activities ...

Millions of Americans living with major depressive disorder struggle to find treatment options that work for them. Providers ...

It’s not uncommon for people with treatment-resistant depression to have problems with drugs or alcohol. While some people may turn to substances to relieve their depression, drinking and drugs can ...

ECT can seem like something out of science fiction, but it actually has decades of studies to show how effective it can be in reducing depression symptoms. Depression is one of the most common mental ...

Psychiatrists and mental health professionals have always relied on medication and talk therapy to treat depression, but Dr. Nicholas Fabiano, a psychiatry resident at the University of Ottawa, thinks ...

At least 30% of people living with depression don’t get any help from at least the first two medications they try. That’s what doctors call treatment-resistant depression. This condition can be very ...

Overall, Contreras underscored that combining predictive analytics, AI-driven modeling, and digital monitoring can help ...

Sign up for CNN’s Stress, But Less newsletter. Our six-part mindfulness guide will inform and inspire you to reduce stress while learning how to harness it. Fournie ...

Please provide your email address to receive an email when new articles are posted on . Managing patients with an illness like chronic kidney disease can be difficult at times for caregivers, but ...

Alto Neuroscience Announces Plans to Accelerate Development of ALTO-207 in Treatment Resistant Depression Following Successful Outcome from Recent FDA Meeting – Successful outcome from recent FDA ...